View the event
| Reference: | 4332 |
| Country: | Turkmenistan |
| Multiple country event: | No |
| Region: | EURO |
| City: | Ashgabad |
| Start date: | 23 June 2012 |
| End date: | 29 June 2012 |
| Estimated duration: | |
| Status: | Completed - Complété |
| | (The mission has taken place) |
|
| Title: | Updating the National M/XDR TB response plan combined with GLC/Europe mission and GDF |
| Type: | Conference (invitation only - avec invitation) |
| Terms of Reference: | Objectives:
• to assess the implementation of the program, evaluate current achievements and sustainability of the program; and develop recommendations for future activities;
• to assess the National M/XDR-TB Response Plan and ensure that it complies with the European M/XDR-TB Response Plan;
• to assess the progress of the implementation of the National M/XDR-TB Response Plan (if available);
• to assess the current M/XDR–TB Control project supported by the Global Fund or any other donor (if applicable).
Key issues to be elaborated and reviewed:
1) Availability of the National M/XDR-TB Response Plan, which includes coverage of all patients including children and adolescents, prisoners and migrants, homeless and etc.;
2) Alignment of the National M/XDR-TB Response Plan to the “Consolidated Action Plan to Prevent and Combat M/XDR-TB in WHO European Region 2011 – 2015”;
3) Identify the need of technical assistance to elaborate and modify the National M/XDR-TB Response Plan;
4) Assess the level of the governmental support and coordination between government and internal and external partners (donors, implementers); the project and the community; civilian and penitentiary system; M/XDR-TB and HIV interventions; human resources management and training;
5) Assess case finding strategies and identify barriers to timely start of M/XDR-TB treatment, including TB in children;
6) Case management and treatment strategies and approaches (clinical protocols and guidelines, side effect management and availability of diagnostics and ancillary drugs at all levels, especially at ambulatory sector); TB children case management; TB care delivery ethics and other relevant aspects of the program with the focus on vulnerable groups (prisoners, former prisoners, migrants and children);
7) Follow up of TB and M/XDR-TB patients; patient-centered approach and social support;
8) Infection control strategies at inpatient and outpatient settings;
9) Current status of laboratory services, diagnostics, accessibility for the patients, including children; collaboration with the supranational reference laboratory;
10) Drug management system for first and second-line TB drugs in terms of quantification method, procurement, importation, storage, distribution and delivery to the patients, availability of children dosages formulation; collaboration with the first and second-line drug procurement agency;
11) Information system (including availability of recording and reporting forms, and data base) and data management (routine collection and cohort analysis); existence of separate MDR-TB register or user-friendly platform for separate data management from the all TB register. Existence of the laboratory information management module linked to MDR-TB and/or TB register.
12) Identify the need, frequency and duration of technical assistance to implement the National M/XDR-TB Response Plan.
|
| Training Opportunity: | No |
| Website: | |
| Purpose 1: | MDR-TB / XDR-TB |
| Purpose 2: | Global Fund grant implementation |
| Purpose 3: | Drug and commodities management |
| Other purpose: | |
|
| Entered by: | Agence de Médecine Préventive (AMP) |
| Partner 1: | |
| Partner 2: | |
| Partner 3: | |
| Contact name: | Bahtygul Karriyeva and Ogtay Gozalov |
| Contact email: | kba@euro.who.int / ogo@euro.who.int |
| Other agencies: | |
|
| Funding needs: | No |
| Funding source: | USAID |
| Other funding source: | |
| Available funding: | $ 8,000 |
| Funding gap: | $ 0 |
| Global Fund reference: | |
|
| Comments: | |
| |
There are no documents attached associated with this event. There are no experts (non-roster) associated with this event.
Date Created: 14 June 2012
Entered By: Europe Office (WHO)
|
